Levin Capital Strategies, L.P. Elanco Animal Health Inc Transaction History
Levin Capital Strategies, L.P.
- $952 Million
- Q2 2024
A detailed history of Levin Capital Strategies, L.P. transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Levin Capital Strategies, L.P. holds 10,000 shares of ELAN stock, worth $140,700. This represents 0.02% of its overall portfolio holdings.
Number of Shares
10,000Holding current value
$140,700% of portfolio
0.02%Shares
5 transactions
Others Institutions Holding ELAN
# of Institutions
447Shares Held
478MCall Options Held
3.1MPut Options Held
1.26M-
Dodge & Cox San Francisco, CA83.6MShares$1.18 Billion0.76% of portfolio
-
Primecap Management CO Pasadena, CA52.8MShares$743 Million0.56% of portfolio
-
Vanguard Group Inc Valley Forge, PA49.4MShares$696 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD28.1MShares$395 Million0.05% of portfolio
-
Black Rock Inc. New York, NY23.3MShares$328 Million0.01% of portfolio
About Elanco Animal Health Inc
- Ticker ELAN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 474,113,984
- Market Cap $6.67B
- Description
- Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...